Uvavanyo lwesifo seswekile lubonisa iimpawu ezisezantsi zobomi kwizigulana ezi-1 kwezi-5
IindabaIsifo seswekile sesinye sesona sifo sixhaphakileyo eMelika, ngokutsho kwamaZiko okuLawula nokuThintela izifo ( i-CDC , kunye nokuxhaphaka kwesifo seswekile kuyanda. Kwi-2018, i-34.2 yezigidi zabantu babenesifo seswekile. Yiyo i-10.5% yabemi base-U.S. Ixabiso leswekile nalo liyenyuka. Iindleko zonyango eziqikelelweyo ngomntu ngamnye onesifo seswekile zonyuke ukusuka kwi- $ 8,417 ngo-2012 ukuya kwi-9,601 yeedola ngo-2017.
I-SingleCare yavavanya abantu abangama-500 abanesifo seswekile ukuba bafunde banzi ngale meko, iindlela zonyango ezinokukhethwa kuzo, kunye nefuthe lazo kubomi baseMelika nakwizipaji.
Ezinxulumene: Izibalo zeswekile
Isishwankathelo seziphumo:
- 1 kwaba-5 abaphendulayo baxela ukuba iimpawu zabo zisehlisa bonke umgangatho wobomi.
- Abaphenduli abancinci bachaphazeleka kakubi kwisifo seswekile kunabaphenduli abadala.
- Phantse ezibini kwisithathu sabaphenduli kuthiwa bachaphazelekayo ukuba imeko yabo ingumngcipheko wokufumana ikhontrakthi ye-COVID-19.
- Olona hlobo luxhaphakileyo lonyango lweswekile phakathi kwabathathi bophando zii-biguanides ezinje nge-metformin.
- Ukusebenza ixesha elide kwe-insulin lolona hlobo luqhelekileyo lwe-insulin phakathi kwabavavanyi bethu.
- Ukuchama rhoqo, ukudinwa, kunye neempawu ze-GI zichazwa njengezona zinto zixhaphakileyo kunyango lweswekile okanye i-insulin.
- I-54% yabaphenduli ihlawula ipokotho ngononophelo lweswekile.
1 kwaba-5 abaphendulayo baxela ukuba iimpawu zabo zisehlisa bonke umgangatho wobomi
Njengesifo esinganyangekiyo, ayothusi into yokuba isifo seswekile sichaphazela ubomi bemihla ngemihla kwizigulana ezininzi zeswekile. Unyango lweswekile Ngokwesiqhelo ifuna utshintsho kwindlela yokuphila esempilweni kunye nonyango lwemihla ngemihla, kwaye iipesenti ezingama-74 zabathathi-nxaxheba baxele ukuba banengxaki yokongezwa kwengqondo kunye / okanye impilo (comorbidity).
- I-48% ixelwe ukuba itye isempilweni.
- I-25% yabo kuthiwa batya besempilweni ikwaxelile ukuba abanangxaki zesifo seswekile okanye iimeko zekomorbid.
- I-30% ixelwe ukuba ingaphezulu kokuzilolonga.
- I-24% yabo baxela ukuba basebenzise ngakumbi baxele ukuba abanangxaki zesifo seswekile okanye iimeko zekomorbid.
- I-30% kuthiwa ayinamandla okwenza imisebenzi yemihla ngemihla.
- I-29% ixeliwe ngemeko yabo kunye / okanye iingxaki ezinokubakho kwisifo seswekile.
- I-34% yaba baphenduliyo ikwafumana iziphumo ebezingalindelekanga ze-GI (isisu esibuhlungu, irhasi, isifo sorhudo, isicaphucaphu, ukugabha), kunye ne-57% ikwachaze ukuba noxinzelelo lwegazi.
- I-19% ixele ukuba iimpawu zabo zinciphisa umgangatho wobomi.
- Kula bantu baphendulileyo, i-13% ikwaxele ukwehla kobunzima, i-21% yaxela usulelo lwegwele, i-20% yaxela uxinzelelo lwegazi oluphantsi, kwaye i-32% yaxela ukuphefumla okuncinci njengeziphumo ebezingalindelekanga kumayeza eswekile.
- Kula bantu baphendulayo, i-16% ikwaxele ukuba inesifo sezintso kwaye i-15% ikwaxele ukuba inesifo sesibindi esinamafutha.
- I-18% kuthiwa ixinezelekile ngemeko yabo.
- I-17% ixele ukuba imeko yabo ayichaphazeli ubomi babo bemihla ngemihla.
- Ngaphezulu kwesiqingatha (i-55%) saba baphenduli baxele ukuba abathathi nyango lweswekile okanye i-insulin.
- Isiqingatha (i-51%) saba baphenduli nabo baxele ukuba abafumani naziphi na iingxaki zeswekile okanye iimeko zekomorbid.
- I-16% ixele imeko yabo ethintela ukuzithemba kwabo.
- Kula bantu baphendulileyo, i-45% ikwaxelile ukuba noxinzelelo lwegazi, i-17% ikwaxelile ukuba ne-hyperlipidemia okanye i-dyslipidemia, i-18% ikwaxelile ukuba inesifo sezintso, i-20% ixelwe ukuba inesifo sesibindi esinamafutha angenalo utywala, i-16% ikwaxele ukuba inesilonda elunyaweni, ukuba nembali yesifo seswekile ketoacidosis.
- I-15% ixele ukuba irejimeni yabo yokunyamekela isifo seswekile ibavumele ukuba baphile ubomi obuphilileyo ngokubanzi.
- Phantse ikota (21%) yabo baxelwe ukuba baphila ubomi obunempilo ngokubanzi bakwachaza ukuba abanangxaki zesifo seswekile okanye iimeko zekomorbid.
- I-13% ixelwe ukuba iyazixakekisa ngendlela abaya kuyifumana ngayo iyeza kunye nezixhobo zabo zeswekile.
- I-8% ixele ukuba imeko yabo ichaphazele kakubi isikolo okanye indlela abaqhuba ngayo emsebenzini.
- I-8% ixele imeko yabo ukuba ibuchaphazele kakubi ubudlelwane babo.
- Aba baphenduli baphinde baxela ukuba baneengxaki zeswekile okanye iimeko zekomorbid. Kula bantu baphendulayo, i-19% ikwaxelwe ukuba ihlaselwe sisifo sentliziyo, i-60% ikwaxele ukuba noxinzelelo lwegazi, i-60% ikwaxele ukutyeba kakhulu okanye ukutyeba kakhulu, i-24% ikwaxelile ukuba inesifo sentliziyo, i-24% ikwaxelile ukuba inesifo sezintso, i-52% ikwatsho ukuba ukulahleka kombono, kwaye i-29% ikwaxele ukuba inesilonda elunyaweni.
- I-1% ichaze ezinye iindlela imeko yabo ichaphazela ubomi babo bemihla ngemihla.
Ezinxulumene: Amanqanaba eswekile yegazi aqhelekileyo
Abaphenduli abancinci bachaphazeleka kakubi kwisifo seswekile kunabaphenduli abadala
Abaphenduli abaneminyaka engamashumi amabini anesihlanu ukuya kwengama-34 ubudala badla ngokuxela iimpembelelo ezimbi ze kwisifo seswekile / Iswekile kubomi bemihla ngemihla.
- I-31% yeli qela leminyaka ixele ukuba iimpawu zabo ziye zehlisa umgangatho wabo wobomi.
- I-28% yeli qela leminyaka ichaze imeko yabo ethintela ukuzithemba kwabo.
- I-28% yeli qela leminyaka ixelwe ukuba ixinezelekile malunga nemeko yabo.
- I-27% yeli qela leminyaka ixelwe ukuba ixhalabile ngemeko yabo kunye / okanye iingxaki ezinokubakho.
- I-21% yeli qela leminyaka ixele ukuba imeko yabo ibuchaphazele kakubi ubudlelwane babo.
- I-15% yeli qela leminyaka ixele ukuba imeko yabo ichaphazele kakubi ukusebenza kwabo esikolweni / emsebenzini.
Kwelinye icala, abaphenduli abaneminyaka engama-55 nangaphezulu ubudala bachaphazeleka kancinci kwimeko yabo.
- I-52% yabaphenduli abaneminyaka engama-55 ukuya kuma-64 nama-51% abaneminyaka engama-65 nangaphezulu baxele ukuba batya besempilweni.
- I-26% yabaphenduli abaneminyaka engama-55 ukuya kuma-64 nama-23% abaneminyaka engama-65 nangaphezulu baxele ukuba imeko yabo ayichaphazeli ubomi babo bemihla ngemihla.
- I-19% yabaphenduli abaneminyaka engama-65 nangaphezulu baxele ukuba irejimeni yabo yokhathalelo lweswekile ibavumele ukuba baphile ubomi obuphilileyo ngokubanzi.
Phantse ezibini kwisithathu sabaphenduli kuthiwa bachaphazelekayo ukuba basemngciphekweni omkhulu wokufumana i-COVID-19 ngenxa yeswekile
Kubaphenduli ekuchazwe ukuba banomdla, i-76% yabo yayinesifo seswekile sohlobo 1. Oku kunomdla kuba abantu abanesifo seswekile sesi-2 babonakala besemngciphekweni omkhulu wokugula kakhulu kwi-coronavirus kunaleyo ine-Type 1, ngokwe i-CDC .
- Ama-62% achaphazelekayo
- I-38% ayichaphazeleki
Olona hlobo luxhaphakileyo lonyango lweswekile phakathi kwabathathi bophando zii-biguanides ezinje nge-metformin
| Ipesenti yabantu abathatha uphando | Iklasi yeziyobisi | Imizekelo yamayeza kwiklasi yeziyobisi |
| 36% | IiBiguanides | IRiomet , Fortamet , Uqhulo , Iglucophage ( metformin ) |
| 19% | I-insulin | |
| 10% | Isulfonylureas | Amaryl , IDiaBeta, iDiabinese, Iswekile yeglucotrol ( glipizide ), IGlycron, Glynase IMicronase, iTol-Tab, iTolinase |
| 9% | I-Incretin mimetics (i-GLP-1 agonists) | Adlyxin, iBydureon, iByetta ,, Ubunzima , UVictoza , Ozempic |
| 7% | IGliptins (inhibitors zeDPP-4) | Januwari , IGalvus, iOnglyza, iTradjenta, iNesina |
| 6% | IGliflozins (SGLT-2 inhibitors) | Steglatro, Ulonwabo , Invokana, Intlanganisela |
| 5% | Thiazolidinediones (TZDs) | I-Avandia , KwiZenzo |
| 4% | Ukudibanisa amayeza | I-Invokamet, IJanumet , Ungqinelwano |
| 3% | I-Alpha-glucosidase inhibitors (ii-AGIs) | IGlyset , Qikelela |
| 3% | Iimpawu ze-Amylin | Symlin |
| 3% | Meglitinides | Prandin, Inkwenkwezi |
Ukongeza, i-5% yabaphenduli bathatha amanye amayeza angadweliswanga apha ngasentla, kwaye i-31% ayithathi amayeza eswekile konke konke.
Ukusebenza ixesha elide kwe-insulin lolona hlobo luqhelekileyo lwe-insulin phakathi kwabavavanyi bethu
| Ipesenti yabantu abathatha uphando | Uhlobo lwe-insulin | Imizekelo yamagama egama insulins |
| 14% | I-insulin esebenza ixesha elide | Toujeo , ILantus , Levemir , UTresiba , I-Basaglar |
| 8% | I-insulin emfutshane | IHululin R, IHumulin R U-500 , UNovolin R , Novolin ReliOn R |
| 8% | I-insulin esebenza ngokukhawuleza | I-Novolog , Fiasp , Apidra, Humalog U-100, Humalog U-200, Admelog |
| 7% | I-insulin exutyiweyo | Uhlobo olufunyenwe 50/50, uHumalog 75/25, I-Novolog 70/30 , IHululin 70/30, uNovolin 70/30 |
| 6% | I-insulin esebenzayo ephakathi | IHumulin N, U-Novolin N. , Novolin ReliOn N |
| 4% | Ukukhawulezisa ukusebenza komgubo wokuphefumla | Afrezz |
| 4% | Ukudibanisa i-insulin | Xultophysi , Soliqua |
Ukongeza, i-2% yabaphenduli bophando bathatha enye i-insulin engadweliswanga apha ngasentla.
Ezinxulumene: Iziphumo ebezingalindelekanga zeMetformin
Ukuchama rhoqo, ukudinwa, kunye neempawu ze-GI zichazwa njengezona zinto zixhaphakileyo kunyango lweswekile okanye i-insulin
- Iipesenti ezingama-24 zichaze ukuchama rhoqo.
- Ukuchama rhoqo kuchaphazela abaphenduli abangamadoda abangaphezulu (30%) kunabafazi (18%).
- Ukuchama rhoqo kuchaphazela uninzi lwabaphenduli abaneminyaka engama-65 nangaphezulu (31%) kunamanye amaqela eminyaka.
- I-24% ichaze ukudinwa.
- I-21% ixele iziphumo ebezingalindelekanga ze-GI (isisu esibuhlungu, irhasi, urhudo, isicaphucaphu, ukugabha).
- Iziphumo ebezingalindelekanga ze-GI zichaphazela uninzi lwabaphenduli babafazi (26%) kunamadoda (17%).
- Iziphumo ebezingalindelekanga ze-GI zichaphazela abaphenduli abaneminyaka yobudala engama-45 ukuya kuma-54 (30%) kunamanye amaqela eminyaka.
- I-11% ixele ilahleko yokutya.
- Ukuphulukana nomdla wokutya kuchaphazela abaphenduli abangamadoda abangaphezulu (14%) kunabasetyhini (8%).
- Ukuphulukana nomdla wokutya kuchaphazela uninzi lwabaphenduli abaneminyaka engama-25 ukuya kuma-34 (19%) kunye nama-35 ukuya kuma-44 (15%) kunamanye amaqela eminyaka.
- I-11% ichaze ukulahleka kobunzima.
- Ukwehla kobunzima kuchaphazela abaphenduli abangamadoda abangaphezulu (14%) kunabasetyhini (8%).
- Ukwehla kobunzima kuchaphazela abaphenduli abaneminyaka engama-25 ukuya kuma-34 (19%) kunye nama-35 ukuya kuma-44 (15%) kunamanye amaqela eminyaka.
- I-24% yabaphenduli abaye baxela irejimeni yabo yokhathalelo lweswekile ibavumele ukuba baphile ubomi obuphilileyo ngokubanzi kwaye i-18% ixele ukuba bayazilolonga kwakhona ikwaxela ukwehla kobunzima njengeziphumo ebezingalindelekanga.
- I-11% ixele ukuphefumla okufutshane.
- Ukuphefumla okufutshane kuchaphazela abaphenduli abaneminyaka engama-65 nangaphezulu (12%) kunamanye amaqela eminyaka.
- I-10% ichaze umchamo omnyama.
- I-8% ixele usulelo lwegwele.
- Usulelo lwegwele luchaphazela abantu abaninzi abaphendulayo (10%) kunamadoda (6%).
- Usulelo lwegwele luchaphazela uninzi lwabaphenduli abaneminyaka engama-25 ukuya kuma-34 (15%) kunamanye amaqela eminyaka.
- I-8% ixele uxinzelelo lwegazi.
- Uxinzelelo lwegazi oluphantsi luchaphazela uninzi lwabaphenduli abaneminyaka engama-25 ukuya kuma-34 (15%) kunye nama-35 ukuya kuma-44 (15%) kunamanye amaqela eminyaka.
- I-8% ixele ezinye iziphumo ebezingalindelekanga (ukutyeba kobunzima kunye nentlungu edibeneyo kunye nethambo) okanye akukho ziphumo ebezingalindelekanga kwaphela.
- I-6% ichaze ukudumba okunzima.
- Ukudumba okukhulu kuchaphazela abantu abaninzi abaphendulayo abaneminyaka engama-55 ukuya kuma-64 (3%) kunamanye amaqela eminyaka.
- I-1% ichaze i-lactic acidosis.
- I-31% ixele ukuba abayithathi iyeza leswekile okanye i-insulin.
Ukuxelwa kweziphumo ebezingalindelekanga zeswekile xa kuthelekiswa ne-insulin ziyahluka
Kulabo bathatha amayeza:
- I-34% ixele iziphumo ebezingalindelekanga ze-GI
- Iipesenti ezingama-35 zichaze ukuchama rhoqo
- I-32% ichaze ukudinwa
- I-15% ixele ukuphefumla okufutshane
- I-8% ixele usulelo lwegwele
- I-5% ixele uxinzelelo lwegazi
Kulabo bathatha i-insulin:
- I-41% ixele iziphumo ebezingalindelekanga ze-GI
- I-27% ixele ukulahleka kwesidlo
- I-18% ixele umchamo omnyama
I-54% yabaphenduli ihlawula ipokotho ngononophelo lweswekile
Ngokwe- Umbutho weSwekile yaseMelika (ADA) , I-67.3% yezonyango ezinxulumene neswekile (uvavanyo lwe-glucose yegazi, amayeza, ukubonelela, ukutyelela ababoneleli ngezempilo, njl.) Kugutyungelwe yiMedicare, iMedicaid, okanye umkhosi; I-30.7% ihlawulwa yi-inshurensi yabucala; kwaye kuphela iipesenti ezi-2 zeendleko ezihlawulwa ngabangaqinisekiswanga. Iziphumo zethu zophando zixelele ibali elifanayo.
- Ama-26% axele ukuba i-inshurensi ihlawula lonke ukhathalelo lwabo lweswekile
- Iipesenti ezingama-20 zichaze ukuba i-Medicare okanye iMedicaid igubungela lonke ukhathalelo lwabo lweswekile
- I-16% ixele ukuba i-inshurensi iyigubungela inkathalelo yabo yeswekile
- I-10% ixele ukuba i-Medicare okanye iMedicaid ngokuyinxenye igubungela ukhathalelo lwabo lweswekile
- I-4% ixele ukuba bahlawula epokothweni ngekhadi lesaphulelo esivela kugqirha (i-SingleCare, i-GoodRx, i-RxSaver, njl.njl.)
- I-3% ixele ukuba bahlawula ipokotho kuyo yonke inkathalo yabo yeswekile
- I-21% ixele ukuba abanalo naluphi na ukhathalelo lweswekile
Ezinxulumene: Ixabisa malini i-insulin?
Indlela yethu:
I-SingleCare yenze olu phando lweswekile kwi-Intanethi nge-AYTM ngo-Okthobha 3, 2020. Le datha yophando ibandakanya abantu abadala base-500 base-US abaneminyaka eli-18 nangaphezulu abathi banesifo seswekile. Isini sahlulwa-hlulwa ngama-50/50.
